ARTICLE | Management Tracks
Plus: Viridian hires Tousignant and an update from Ligand
By Richard Guy, Biopharma Analyst
February 17, 2024 12:56 AM UTC


Cancer company OnKure Inc. hired Samuel Agresta as CMO. Agresta was CMO at Foghorn Therapeutics Inc. (NASDAQ:FHTX).
Viridian Therapeutics Inc. (NASDAQ:VRDN) hired Jennifer Tousignant, former SVP of legal at Sana Biotechnology Inc. (NASDAQ:SANA), as chief legal officer. Viridian is developing IGF1R-targeting antibody VRDN-001 to treat thyroid eye disease. …
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/651477/agresta-joining-onkure-as-cmo